Lumos Diagnostics Holdings Limited (LDX.AX)
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States.
0.10-0.09%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+23.5%
The outlook
Lumos Diagnostics Holdings Limited currently reads as neutral based on strong buy — 1.0 avg of 1 analysts, below its 50- & 200-day averages, 11% of the way from its 52-week low to high, avg target +150% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +150% vs current price
Market cap
$94.5M
52-wk high
0.33
52-wk low
0.07
50-day avg
0.10
200-day avg
0.20
Trailing P/E
—